Use of Artificial Intelligence–Based Detection of Diabetic Retinopathy in the US

Abstract

This cohort study examines patient data from January 2019 to December 2023 to evaluate national trends in the use of artificial intelligence–based screenings to detect diabetic retinopathy among patients with types 1 or 2 diabetes.